Cargando…

P16-44. Investigating T cell immune responses in Cameroon, a country with broad HIV-1 genetic diversity

Detalles Bibliográficos
Autores principales:	Tongo, M, Ebong, E, Zembe, L, Ngole, E Mpoudi, Burgers, W
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767774/ http://dx.doi.org/10.1186/1742-4690-6-S3-P273

Ejemplares similares

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
por: Tongo, Marcel, et al.
Publicado: (2013)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

Refined identification of neutralization-resistant CRF02_AG viruses and their sensitivity to anti-MPER neutralizing antibodies
por: Jacob, RA, et al.
Publicado: (2012)

Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country
por: Tongo, Marcel, et al.
Publicado: (2015)

HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007)

Genetic characterization of HIV-1 subtype G envelope sequences by single genome analysis
por: Rene Ghislain, E, et al.
Publicado: (2012)

Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
por: Aghokeng, Avelin F., et al.
Publicado: (2009)

HIV-1 diversity in Cameroon: new insights on the evolution of the virus
por: Simon, T Aime Marcel, et al.
Publicado: (2012)

Genetic diversity and high proportion of intersubtype recombinants of HIV-1 in urban Cameroon
por: Machuca, Ana, et al.
Publicado: (2006)

Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity
por: Tongo, Marcel, et al.
Publicado: (2014)

P16-49. Broad types of cytokines secreted by Gag-specific T cells from HIV infected patients on HAART
por: Montes, M, et al.
Publicado: (2009)

Study of intestinal parasitic infections associated with HIV infection in Douala, Cameroon
por: Lehman, Leopold G, et al.
Publicado: (2012)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics?
por: Carr, Jean K, et al.
Publicado: (2010)

Family support unit improves care and support to HIV-infected children and their caregivers in Cameroon
por: Kwah, CN, et al.
Publicado: (2006)

P04-46. Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
por: Fenyö, E, et al.
Publicado: (2009)

Simian T-Lymphotropic Virus Diversity among Nonhuman Primates, Cameroon
por: Sintasath, David M., et al.
Publicado: (2009)

HIV risk behaviors and condom use in west region of Cameroon: need for HIV prevention strategies shifted towards HIV seropositive individuals
por: Nkenfou, Celine, et al.
Publicado: (2014)

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon
por: Aghokeng, Avelin F, et al.
Publicado: (2013)

5593300 INVESTIGATIONS OF KIDNEY DYSFUNCTION-RELATED GENE VARIANTS IN SICKLE CELL DISEASE PATIENTS IN CAMEROON (SUB-SAHARAN AFRICA)
por: NGO BITOUNGUI, V.B., et al.
Publicado: (2023)

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies
por: Julien, J, et al.
Publicado: (2012)

Investigating Eucalyptus – pathogen and pest interactions to dissect broad spectrum defense mechanisms
por: Naidoo, Sanushka, et al.
Publicado: (2011)

Exposure to Nonhuman Primates in Rural Cameroon
por: Wolfe, Nathan D., et al.
Publicado: (2004)

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon
por: Agyingi, L, et al.
Publicado: (2012)

Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
por: Han, D, et al.
Publicado: (2012)

Novel vomputational methods for predicting epitopes of potent and broadly neutralizing HIV-1 antibodies
por: Evans, MC, et al.
Publicado: (2012)

Further confirmation of broadly conserved, highly immunogenic cross-clade HIV CTL epitopes for inclusion in the GAIA HIV vaccine
por: De Groot, AS, et al.
Publicado: (2012)

Penile cancers without the AIDS epidemic in Cameroon
por: Nkegoum, Blaise
Publicado: (2012)

Noninvasive western lowland gorilla's health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon
por: Villabona‐Arenas, Christian Julian, et al.
Publicado: (2018)

P04-51 LB. The epitopes of two newly identified broad and potent neutralizing antibodies, PG9 and PG16
por: Walker, L, et al.
Publicado: (2009)

Juvenile localized scleroderma: review of 44 patients
por: Iglesias, E, et al.
Publicado: (2011)

Antiretroviral Drug Resistance and Routine Therapy, Cameroon
por: Laurent, Christian, et al.
Publicado: (2006)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

Assessment of human resources capacity of pharmaceutical warehouses in Cameroon
por: Ayuk, Samuel Ottu, et al.
Publicado: (2014)

P04-06. Evolution of an anti-MPER gp41 antibody response that mediates broad HIV-1 cross-neutralization
por: Gray, E, et al.
Publicado: (2009)

Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
por: Levy, Y, et al.
Publicado: (2012)

P04-53 LB. Potent and broad HIV-specific neutralizing antibodies in infants are not associated with prevention of mother to infant HIV transmission
por: Lynch, J, et al.
Publicado: (2009)

Commercial Logging and HIV Epidemic, Rural Equatorial Africa
por: Laurent, Christian, et al.
Publicado: (2004)

P04-44. Generation of antibody responses to HIV-1 membrane proximal external region (MPER) antigen
por: Holl, TM, et al.
Publicado: (2009)

Broad and potent neutralization of HIV-1 by human-llama fusion antibodies derived from immunized llamas
por: McCoy, LE, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c6tr7gnpb6meb0ckg74a63g48e